Furthermore, the CVS and PRL have proven to be effective for differentiating MS from mimicking diseases (Ontaneda et al., 2021, Sati et al., 2016, Clarke et al., 2020, Maggi et al., 2020). The gene discussed is PRL; the disease is myeloid sarcoma.